{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:42:44Z","timestamp":1786992164698,"version":"build-2736575974"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The opening foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine","award":["SKLID2024KF07"],"award-info":[{"award-number":["SKLID2024KF07"]}]},{"name":"Talent Introduction Project of Zhejiang Shuren University","award":["KXJ1723105"],"award-info":[{"award-number":["KXJ1723105"]}]},{"name":"Zhejiang Shuren University Basic Scientific Research Special Funds","award":["KXJ1724104C and 2024XZ013"],"award-info":[{"award-number":["KXJ1724104C and 2024XZ013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01183-9","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:19:26Z","timestamp":1773238766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hepatocellular carcinoma and vitamin D metabolism: novel targets and therapeutic strategies"],"prefix":"10.1007","volume":"49","author":[{"given":"Hanlin","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"12","key":"1183_CR1","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","volume":"8","author":"J Qi","year":"2023","unstructured":"J. Qi, M. Li, L. Wang, Y. Hu, W. Liu, Z. Long, Z. Zhou, P. Yin, M. Zhou, National and subnational trends in cancer burden in China, 2005\u201320: an analysis of national mortality surveillance data. Lancet Public. Health. 8(12), e943\u2013e955 (2023)","journal-title":"Lancet Public. Health"},{"issue":"19","key":"1183_CR2","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1097\/CM9.0000000000003264","volume":"137","author":"Q Li","year":"2024","unstructured":"Q. Li, C. Ding, M. Cao, F. Yang, X. Yan, S. He, M. Cao, S. Zhang, Y. Teng, N. Tan et al., Global epidemiology of liver cancer 2022: An emphasis on geographic disparities. Chin. Med. J. (Engl). 137(19), 2334\u20132342 (2024)","journal-title":"Chin. Med. J. (Engl)"},{"issue":"1","key":"1183_CR3","doi-asserted-by":"publisher","first-page":"13120","DOI":"10.1038\/s41598-025-96615-1","volume":"15","author":"Z Zhan","year":"2025","unstructured":"Z. Zhan, B. Chen, R. Huang, W. Lin, S. Lan, X. Yao, S. Huang, W. Lin, S. Xu, S. Zhou, Long-term trends and future projections of liver cancer burden in China from 1990 to 2030. Sci. Rep. 15(1), 13120 (2025)","journal-title":"Sci. Rep."},{"key":"1183_CR4","doi-asserted-by":"crossref","unstructured":"C. Chen, Q. Xu, T. Wang, Y. Yuan, Z. Hu, X. Li, X. Zheng, H. Lei, Comparative analysis of liver cancer burden trends in China and worldwide between 1990 and 2021. Front. Public. Health 13, (2025)","DOI":"10.3389\/fpubh.2025.1513210"},{"issue":"1","key":"1183_CR5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3390\/curroncol30010071","volume":"30","author":"Y Zhao","year":"2023","unstructured":"Y. Zhao, D. Yang, Y. Yan, X. Zhang, N. Yang, Y. Guo, C. Yu, Secular trends of liver cancer mortality and years of life lost in Wuhan, China 2010\u20132019. Curr. Oncol. 30(1), 938\u2013948 (2023)","journal-title":"Curr. Oncol."},{"issue":"1","key":"1183_CR6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/s12885-024-12334-2","volume":"24","author":"Y Qin","year":"2024","unstructured":"Y. Qin, C. Tang, J. Li, J. Gong, Liver cancer in China: the analysis of mortality and burden of disease trends from 2008 to 2021. BMC cancer. 24(1), 594 (2024)","journal-title":"BMC cancer"},{"issue":"4","key":"1183_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.14218\/JCTH.2023.00455","volume":"12","author":"H Liu","year":"2024","unstructured":"H. Liu, X. Wang, L. Wang, P. Yin, F. Liu, L. Wei, Y. Wang, M. Zhou, J. Qi, H. Rao, Mortality burden of liver cancer in China: an observational study from 2008 to 2020. J. Clin. translational Hepatol. 12(4), 371 (2024)","journal-title":"J. Clin. translational Hepatol."},{"key":"1183_CR8","doi-asserted-by":"crossref","unstructured":"Z. Hui, W. Yu, W. Fuzhen, S. Liping, Z. Guomin, L. Jianhua, W. Feng, M. Ning, L. Jian, D. Guowei, New progress in HBV control and the cascade of health care for people living with HBV in China: Evidence from the fourth national serological survey, 2020. Lancet Reg. Health West. Pac. 51, (2024)","DOI":"10.1016\/j.lanwpc.2024.101193"},{"issue":"2","key":"1183_CR9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.17998\/jlc.2023.08.27","volume":"23","author":"JH Yoon","year":"2023","unstructured":"J.H. Yoon, S.K. Choi, Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes. J. Liver Cancer. 23(2), 300\u2013315 (2023)","journal-title":"J. Liver Cancer"},{"issue":"9","key":"1183_CR10","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/s41416-023-02188-z","volume":"128","author":"A Cucchetti","year":"2023","unstructured":"A. Cucchetti, O. Elshaarawy, G. Han, C.C. Chong, C. Serra, J.M. O\u2019Rourke, R. Crew, C. Felicani, G. Ercolani, T. Shah, Potentially curative therapies\u2019 for hepatocellular carcinoma: how many patients can actually be cured? Br. J. Cancer. 128(9), 1665\u20131671 (2023)","journal-title":"Br. J. Cancer"},{"issue":"2","key":"1183_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","volume":"42","author":"X Yang","year":"2024","unstructured":"X. Yang, C. Yang, S. Zhang, H. Geng, A.X. Zhu, R. Bernards, W. Qin, J. Fan, C. Wang, Q. Gao, Precision treatment in advanced hepatocellular carcinoma. Cancer Cell. 42(2), 180\u2013197 (2024)","journal-title":"Cancer Cell."},{"issue":"2","key":"1183_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1158\/0008-5472.CAN-15-3169","volume":"76","author":"JR Bertino","year":"2016","unstructured":"J.R. Bertino, Landmark study: the relation of solar radiation to cancer mortality in North America. Cancer Res. 76(2), 185\u2013185 (2016)","journal-title":"Cancer Res."},{"issue":"3","key":"1183_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/ije\/9.3.227","volume":"9","author":"CF Garland","year":"1980","unstructured":"C.F. Garland, F.C. Garland, Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol. 9(3), 227\u2013231 (1980)","journal-title":"Int. J. Epidemiol."},{"issue":"12","key":"1183_CR14","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1002\/1097-0142(19921215)70:12<2861::AID-CNCR2820701224>3.0.CO;2-G","volume":"70","author":"CL Hanchette","year":"1992","unstructured":"C.L. Hanchette, G.G. Schwartz, Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer. 70(12), 2861\u20132869 (1992)","journal-title":"Cancer"},{"issue":"1","key":"1183_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10654-022-00921-1","volume":"38","author":"K Visvanathan","year":"2023","unstructured":"K. Visvanathan, A.M. Mondul, A. Zeleniuch-Jacquotte, M. Wang, M.H. Gail, S.S. Yaun, S.J. Weinstein, M.L. McCullough, A.H. Eliassen, N.R. Cook et al., Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts. Eur. J. Epidemiol. 38(1), 11\u201329 (2023)","journal-title":"Eur. J. Epidemiol."},{"issue":"11","key":"1183_CR16","doi-asserted-by":"publisher","first-page":"8390","DOI":"10.3390\/curroncol29110661","volume":"29","author":"X Liu","year":"2022","unstructured":"X. Liu, Y. Zhou, X. Zou, Correlation between Serum 25-Hydroxyvitamin D Levels and Gastric Cancer: A Systematic Review and Meta-Analysis. Curr. Oncol. 29(11), 8390\u20138400 (2022)","journal-title":"Curr. Oncol."},{"issue":"1","key":"1183_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12937-025-01146-0","volume":"24","author":"S Song","year":"2025","unstructured":"S. Song, H.D. Woo, J. Lyu, B.M. Song, J.-Y. Lim, H.-Y. Park, Serum 25-hydroxyvitamin D levels and risk of overall and site-specific cancers in Korean adults: results from two prospective cohort studies. Nutr. J. 24(1), 84 (2025)","journal-title":"Nutr. J."},{"issue":"3","key":"1183_CR18","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00394-023-03302-w","volume":"63","author":"Y Shen","year":"2024","unstructured":"Y. Shen, J. Xia, C. Yi, T. Li, P. Wang, L. Dai, J. Shi, K. Wang, C. Sun, H. Ye, The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies. Eur. J. Nutr. 63(3), 653\u2013672 (2024)","journal-title":"Eur. J. Nutr."},{"issue":"5","key":"1183_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1089\/jwh.2022.0432","volume":"32","author":"S Jung","year":"2023","unstructured":"S. Jung, S. Jin, Y. Je, D. Vitamin, Intake, Blood 25-Hydroxyvitamin D, and Risk of Ovarian Cancer: A Meta-Analysis of Observational Studies. J. Womens Health (Larchmt). 32(5), 561\u2013573 (2023)","journal-title":"J. Womens Health (Larchmt)"},{"issue":"6","key":"1183_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1158\/1055-9965.EPI-15-1162","volume":"25","author":"L Zgaga","year":"2016","unstructured":"L. Zgaga, F. O\u2019Sullivan, M.M. Cantwell, L.J. Murray, P.N. Thota, H.G. Coleman, Markers of Vitamin D Exposure and Esophageal Cancer Risk: A Systematic Review and Meta-analysis. Cancer Epidemiol. Biomarkers Prev. 25(6), 877\u2013886 (2016)","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"3","key":"1183_CR21","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s13277-014-2728-9","volume":"36","author":"Y Liao","year":"2015","unstructured":"Y. Liao, J.L. Huang, M.X. Qiu, Z.W. Ma, Impact of serum vitamin D level on risk of bladder cancer: a systemic review and meta-analysis. Tumour Biol. 36(3), 1567\u20131572 (2015)","journal-title":"Tumour Biol."},{"issue":"4","key":"1183_CR22","doi-asserted-by":"publisher","first-page":"991","DOI":"10.31557\/APJCP.2021.22.4.991","volume":"22","author":"Z Yi","year":"2021","unstructured":"Z. Yi, L. Wang, X. Tu, Effect of Vitamin D Deficiency on Liver Cancer Risk: A Systematic Review and Meta-Analysis. Asian Pac. J. Cancer Prev. 22(4), 991\u2013997 (2021)","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"1183_CR23","doi-asserted-by":"crossref","unstructured":"T. Lawler, S. Warren Andersen, Serum 25-hydroxyvitamin D and cancer risk: a systematic review of Mendelian randomization studies. Nutrients 15(2), (2023)","DOI":"10.3390\/nu15020422"},{"issue":"6","key":"1183_CR24","first-page":"1339","volume":"5","author":"DC Smith","year":"1999","unstructured":"D.C. Smith, C.S. Johnson, C.C. Freeman, J. Muindi, J.W. Wilson, D.L. Trump, A Phase I trial of calcitriol (1, 25-dihydroxycholecalciferol) in patients with advanced malignancy. Clin. Cancer Res. 5(6), 1339\u20131345 (1999)","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"1183_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa1809944","volume":"380","author":"JE Manson","year":"2019","unstructured":"J.E. Manson, N.R. Cook, I.-M. Lee, W. Christen, S.S. Bassuk, S. Mora, H. Gibson, D. Gordon, T. Copeland, D. D\u2019Agostino, Vitamin D supplements and prevention of cancer and cardiovascular disease. N. Engl. J. Med. 380(1), 33\u201344 (2019)","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"1183_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1042\/BJ20110744","volume":"441","author":"JC Fleet","year":"2012","unstructured":"J.C. Fleet, M. DeSmet, R. Johnson, Y. Li, Vitamin D and cancer: a review of molecular mechanisms. Biochem. J. 441(1), 61\u201376 (2012)","journal-title":"Biochem. J."},{"issue":"4","key":"1183_CR27","first-page":"1","volume":"50","author":"S-M Jeon","year":"2018","unstructured":"S.-M. Jeon, E.-A. Shin, Exploring vitamin D metabolism and function in cancer. Exp. Mol. Med. 50(4), 1\u201314 (2018)","journal-title":"Exp. Mol. Med."},{"key":"1183_CR28","doi-asserted-by":"publisher","first-page":"104866","DOI":"10.1016\/j.yexmp.2023.104866","volume":"132","author":"G Daryabor","year":"2023","unstructured":"G. Daryabor, N. Gholijani, F.R. Kahmini, A review of the critical role of vitamin D axis on the immune system. Exp. Mol. Pathol. 132, 104866 (2023)","journal-title":"Exp. Mol. Pathol."},{"key":"1183_CR29","doi-asserted-by":"publisher","first-page":"950465","DOI":"10.3389\/fimmu.2023.950465","volume":"14","author":"A Ghaseminejad-Raeini","year":"2023","unstructured":"A. Ghaseminejad-Raeini, A. Ghaderi, A. Sharafi, B. Nematollahi-Sani, M. Moossavi, A. Derakhshani, G.A. Sarab, Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review. Front. Immunol. 14, 950465 (2023)","journal-title":"Front. Immunol."},{"issue":"3","key":"1183_CR30","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cmet.2017.02.006","volume":"25","author":"N Zmora","year":"2017","unstructured":"N. Zmora, S. Bashiardes, M. Levy, E. Elinav, The role of the immune system in metabolic health and disease. Cell Metabol. 25(3), 506\u2013521 (2017)","journal-title":"Cell Metabol."},{"issue":"2","key":"1183_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/10409238.2019.1611734","volume":"54","author":"MT Cantorna","year":"2019","unstructured":"M.T. Cantorna, L. Snyder, J. Arora, Vitamin A and vitamin D regulate the microbial complexity, barrier function, and the mucosal immune responses to ensure intestinal homeostasis. Crit. Rev. Biochem. Mol. Biol. 54(2), 184\u2013192 (2019)","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"1183_CR32","unstructured":"D.D. Bikle, Vitamin D: production, metabolism and mechanisms of action. 2015"},{"issue":"1","key":"1183_CR33","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12885-023-10690-z","volume":"23","author":"J Yu","year":"2023","unstructured":"J. Yu, Q. Sun, Y. Hui, J. Xu, P. Shi, Y. Chen, Y. Chen, Vitamin D receptor prevents tumour development by regulating the Wnt\/\u03b2-catenin signalling pathway in human colorectal cancer. BMC cancer. 23(1), 336 (2023)","journal-title":"BMC cancer"},{"key":"1183_CR34","doi-asserted-by":"publisher","first-page":"642653","DOI":"10.3389\/fonc.2021.642653","volume":"11","author":"IB Adelani","year":"2021","unstructured":"I.B. Adelani, O.A. Rotimi, E.N. Maduagwu, S.O. Rotimi, Vitamin D: Possible Therapeutic Roles in Hepatocellular Carcinoma. Front. Oncol. 11, 642653 (2021)","journal-title":"Front. Oncol."},{"issue":"2","key":"1183_CR35","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3892\/mmr.2015.4676","volume":"13","author":"J Huang","year":"2016","unstructured":"J. Huang, G. Yang, Y. Huang, W. Kong, S. Zhang, 1, 25 (OH) 2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21 (WAFI\/CIP1). Mol. Med. Rep. 13(2), 1373\u20131380 (2016)","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"1183_CR36","doi-asserted-by":"publisher","first-page":"11695","DOI":"10.1038\/s41598-019-48081-9","volume":"9","author":"DP Provvisiero","year":"2019","unstructured":"D.P. Provvisiero, M. Negri, de C. Angelis, Di G. Gennaro, R. Patalano, C. Simeoli, F. Papa, R. Ferrigno, R.S. Auriemma, De M.C. Martino, Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375\/oncogenes circuit. Sci. Rep. 9(1), 11695 (2019)","journal-title":"Sci. Rep."},{"issue":"2","key":"1183_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ecl.2010.02.002","volume":"39","author":"S Christakos","year":"2010","unstructured":"S. Christakos, D.V. Ajibade, P. Dhawan, A.J. Fechner, L.J. Mady, Vitamin D: metabolism. Endocrinol. Metab. Clin. North Am. 39(2), 243 (2010)","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"11","key":"1183_CR38","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1080\/10408398.2020.1862753","volume":"62","author":"MR Meza-Meza","year":"2022","unstructured":"M.R. Meza-Meza, A.I. Ruiz-Ballesteros, U. de la Cruz-Mosso, Functional effects of vitamin D: From nutrient to immunomodulator. Crit. Rev. Food Sci. Nutr. 62(11), 3042\u20133062 (2022)","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"8","key":"1183_CR39","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/10408363.2022.2070595","volume":"59","author":"J Janou\u0161ek","year":"2022","unstructured":"J. Janou\u0161ek, V. Pila\u0159ov\u00e1, K. Mac\u00e1kov\u00e1, A. Nomura, J. Veiga-Matos, F. Silva DDd, Remiao, L. Saso, K. Mal\u00e1-L\u00e1dov\u00e1, J. Mal\u00fd, Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites. Crit. Rev. Clin. Lab. Sci. 59(8), 517\u2013554 (2022)","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"4","key":"1183_CR40","doi-asserted-by":"publisher","first-page":"E326","DOI":"10.1152\/ajpendo.1983.245.4.E326","volume":"245","author":"S Dueland","year":"1983","unstructured":"S. Dueland, P. Helgerud, J. Pedersen, T. Berg, C.A. Drevon, Plasma clearance, transfer, and distribution of vitamin D3 from intestinal lymph. Am. J. Physiology-Endocrinology Metabolism. 245(4), E326\u2013E331 (1983)","journal-title":"Am. J. Physiology-Endocrinology Metabolism"},{"key":"1183_CR41","doi-asserted-by":"crossref","unstructured":"J.B. Cheng, M.A. Levine, N.H. Bell, D.J. Mangelsdorf, D.W. Russell, Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. U.S.A. 101(20), 7711\u20137715 (2004)","DOI":"10.1073\/pnas.0402490101"},{"issue":"1","key":"1183_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jnutbio.2013.09.003","volume":"25","author":"JH Ooi","year":"2014","unstructured":"J.H. Ooi, K.L. McDaniel, V. Weaver, M.T. Cantorna, Murine CD8\u2009+\u2009T cells but not macrophages express the vitamin D 1\u03b1-hydroxylase. J. Nutr. Biochem. 25(1), 58\u201365 (2014)","journal-title":"J. Nutr. Biochem."},{"issue":"2","key":"1183_CR43","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1681\/ASN.2016010066","volume":"28","author":"L Nguyen-Yamamoto","year":"2017","unstructured":"L. Nguyen-Yamamoto, A.C. Karaplis, R. St-Arnaud, D. Goltzman, Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D. J. Am. Soc. Nephrol. 28(2), 586\u2013597 (2017)","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"1183_CR44","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/exd.13760","volume":"27","author":"W Wu","year":"2018","unstructured":"W. Wu, H. Fan, Y. Jiang, L. Liao, L. Li, J. Zhao, H. Zhang, C. Shrestha, Z. Xie, Regulation of 25-hydroxyvitamin D-1-hydroxylase and 24-hydroxylase in keratinocytes by PTH and FGF23. Exp. Dermatol. 27(11), 1201\u20131209 (2018)","journal-title":"Exp. Dermatol."},{"issue":"3","key":"1183_CR45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","volume":"21","author":"DD Bikle","year":"2014","unstructured":"D.D. Bikle, Vitamin D metabolism, mechanism of action, and clinical applications. Chem. Biol. 21(3), 319\u2013329 (2014)","journal-title":"Chem. Biol."},{"issue":"11","key":"1183_CR46","doi-asserted-by":"publisher","first-page":"e10397","DOI":"10.1002\/jbm4.10397","volume":"4","author":"MS Elkhwanky","year":"2020","unstructured":"M.S. Elkhwanky, O. Kummu, T.T. Piltonen, J. Laru, L. Morin-Papunen, M. Mutikainen, P. Tavi, J. Hakkola, Obesity Represses CYP2R1, the Vitamin D 25-Hydroxylase, in the Liver and Extrahepatic Tissues. JBMR Plus. 4(11), e10397 (2020)","journal-title":"JBMR Plus"},{"key":"1183_CR47","doi-asserted-by":"crossref","unstructured":"T.L. Pop, C. S\u00eerbe, G. Ben\u0163a, A. Mititelu, A. Grama, The role of Vitamin D and vitamin D binding protein in chronic liver diseases. Int. J. Mol. Sci. 23(18), (2022)","DOI":"10.3390\/ijms231810705"},{"issue":"5","key":"1183_CR48","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1053\/jhep.2003.50176","volume":"37","author":"M Gascon-Barr\u00e9","year":"2003","unstructured":"M. Gascon-Barr\u00e9, C. Demers, A. Mirshahi, S. N\u00e9ron, S. Zalzal, A. Nanci, The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells. Hepatology. 37(5), 1034\u20131042 (2003)","journal-title":"Hepatology"},{"key":"1183_CR49","doi-asserted-by":"crossref","unstructured":"I. Aggeletopoulou, E.P. Tsounis, C. Triantos, Vitamin D and metabolic dysfunction-associated steatotic liver disease (MASLD): novel mechanistic insights. Int. J. Mol. Sci. 25(9), (2024)","DOI":"10.3390\/ijms25094901"},{"issue":"10","key":"1183_CR50","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1177\/1535370220987524","volume":"246","author":"H Lim","year":"2021","unstructured":"H. Lim, H. Lee, Y. Lim, Effect of vitamin D(3) supplementation on hepatic lipid dysregulation associated with autophagy regulatory AMPK\/Akt-mTOR signaling in type 2 diabetic mice. Exp. Biol. Med. (Maywood). 246(10), 1139\u20131147 (2021)","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"9","key":"1183_CR51","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.3390\/ijms25094901","volume":"25","author":"I Aggeletopoulou","year":"2024","unstructured":"I. Aggeletopoulou, E.P. Tsounis, C. Triantos, Vitamin D and metabolic dysfunction-associated steatotic liver disease (MASLD): Novel mechanistic insights. Int. J. Mol. Sci. 25(9), 4901 (2024)","journal-title":"Int. J. Mol. Sci."},{"key":"1183_CR52","doi-asserted-by":"crossref","unstructured":"Z. Rao, X. Chen, J. Wu, M. Xiao, J. Zhang, B. Wang, L. Fang, H. Zhang, X. Wang, S. Yang et al., Vitamin D receptor inhibits NLRP3 activation by impeding its BRCC3-mediated deubiquitination. Front. Immunol. 10, (2019)","DOI":"10.3389\/fimmu.2019.02783"},{"key":"1183_CR53","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fphar.2020.00200","volume":"11","author":"X Wang","year":"2020","unstructured":"X. Wang, G. Wang, J. Qu, Z. Yuan, R. Pan, K. Li, Calcipotriol Inhibits NLRP3 Signal Through YAP1 Activation to Alleviate Cholestatic Liver Injury and Fibrosis. Front. Pharmacol. 11, 200 (2020)","journal-title":"Front. Pharmacol."},{"issue":"3","key":"1183_CR54","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","volume":"153","author":"N Ding","year":"2013","unstructured":"N. Ding, R.T. Yu, N. Subramaniam, M.H. Sherman, C. Wilson, R. Rao, M. Leblanc, S. Coulter, M. He, C. Scott et al., A vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response. Cell. 153(3), 601\u2013613 (2013)","journal-title":"Cell"},{"issue":"5","key":"1183_CR55","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/gutjnl-2014-307024","volume":"64","author":"A Beilfuss","year":"2015","unstructured":"A. Beilfuss, J.P. Sowa, S. Sydor, M. Beste, L.P. Bechmann, M. Schlattjan, W.K. Syn, I. Wedemeyer, Z. Math\u00e9, C. Jochum et al., Vitamin D counteracts fibrogenic TGF-\u03b2 signalling in human hepatic stellate cells both receptor-dependently and independently. Gut. 64(5), 791\u2013799 (2015)","journal-title":"Gut"},{"issue":"2","key":"1183_CR56","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3325\/cmj.2022.63.187","volume":"63","author":"A Markoti\u0107","year":"2022","unstructured":"A. Markoti\u0107, T. Kelava, H. Markoti\u0107, H. Silovski, A. Mrzljak, Vitamin D in liver cancer: novel insights and future perspectives. Croat Med. J. 63(2), 187\u2013196 (2022)","journal-title":"Croat Med. J."},{"issue":"10","key":"1183_CR57","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3109\/13880209.2014.988274","volume":"53","author":"M Giammanco","year":"2015","unstructured":"M. Giammanco, Di D. Majo, La M. Guardia, S. Aiello, M. Crescimannno, C. Flandina, F.M. Tumminello, G. Leto, Vitamin D in cancer chemoprevention. Pharm. Biol. 53(10), 1399\u20131434 (2015)","journal-title":"Pharm. Biol."},{"issue":"1","key":"1183_CR58","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41698-018-0048-z","volume":"2","author":"L-X Yu","year":"2018","unstructured":"L.-X. Yu, Y. Ling, H.-Y. Wang, Role of nonresolving inflammation in hepatocellular carcinoma development and progression. NPJ precision Oncol. 2(1), 6 (2018)","journal-title":"NPJ precision Oncol."},{"key":"1183_CR59","doi-asserted-by":"publisher","first-page":"760971","DOI":"10.3389\/fonc.2021.760971","volume":"11","author":"J Xu","year":"2021","unstructured":"J. Xu, H. Lin, G. Wu, M. Zhu, M. Li, IL-6\/STAT3 is a promising therapeutic target for hepatocellular carcinoma. Front. Oncol. 11, 760971 (2021)","journal-title":"Front. Oncol."},{"issue":"33","key":"1183_CR60","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.2174\/09298673113209990248","volume":"20","author":"J Guo","year":"2013","unstructured":"J. Guo, Z. Ma, Q. Ma, Z. Wu, P. Fan, X. Zhou, L. Chen, S. Zhou, D. Goltzman, D. Miao et al., 1, 25(OH)\u2082D\u2083 inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes. Curr. Med. Chem. 20(33), 4131\u20134141 (2013)","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"1183_CR61","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/reports4020017","volume":"4","author":"V Rai","year":"2021","unstructured":"V. Rai, D.K. Agrawal, Regulation of TREM1-Mediated Inflammation in Hepatocellular Carcinoma Cells. Reports. 4(2), 17 (2021)","journal-title":"Reports"},{"issue":"17","key":"1183_CR62","doi-asserted-by":"publisher","first-page":"11681","DOI":"10.1074\/jbc.M113.517581","volume":"289","author":"Q Wang","year":"2014","unstructured":"Q. Wang, Y. He, Y. Shen, Q. Zhang, D. Chen, C. Zuo, J. Qin, H. Wang, J. Wang, Y. Yu, Vitamin D inhibits COX-2 expression and inflammatory response by targeting thioesterase superfamily member 4. J. Biol. Chem. 289(17), 11681\u201311694 (2014)","journal-title":"J. Biol. Chem."},{"issue":"5","key":"1183_CR63","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/hep.30937","volume":"71","author":"B Dong","year":"2020","unstructured":"B. Dong, Y. Zhou, W. Wang, J. Scott, K. Kim, Z. Sun, Q. Guo, Y. Lu, N.M. Gonzales, H. Wu, Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice. Hepatology. 71(5), 1559\u20131574 (2020)","journal-title":"Hepatology"},{"key":"1183_CR64","doi-asserted-by":"publisher","first-page":"109699","DOI":"10.1016\/j.abb.2023.109699","volume":"744","author":"L Xing","year":"2023","unstructured":"L. Xing, Y. Tang, L. Li, X. Tao, ROS in hepatocellular carcinoma: What we know. Arch. Biochem. Biophys. 744, 109699 (2023)","journal-title":"Arch. Biochem. Biophys."},{"key":"1183_CR65","doi-asserted-by":"crossref","unstructured":"E. Vidak, U. Javor\u0161ek, M. Vizovi\u0161ek, B. Turk, Cysteine cathepsins and their extracellular roles: shaping the microenvironment. Cells 8(3), (2019)","DOI":"10.3390\/cells8030264"},{"issue":"13","key":"1183_CR66","doi-asserted-by":"publisher","first-page":"10749","DOI":"10.18632\/aging.205955","volume":"16","author":"Y Wu","year":"2024","unstructured":"Y. Wu, D. Jiang, Q. Liu, S. Yan, X. Liu, T. Wu, W. Sun, G. Li, Cathepsin L induces cellular senescence by upregulating CUX1 and p16(INK4a). Aging (Albany NY). 16(13), 10749\u201310764 (2024)","journal-title":"Aging (Albany NY)"},{"issue":"11","key":"1183_CR67","doi-asserted-by":"publisher","first-page":"e112136","DOI":"10.1371\/journal.pone.0112136","volume":"9","author":"J Ruan","year":"2014","unstructured":"J. Ruan, H. Zheng, W. Fu, P. Zhao, N. Su, R. Luo, Increased expression of cathepsin L: a novel independent prognostic marker of worse outcome in hepatocellular carcinoma patients. PLoS One. 9(11), e112136 (2014)","journal-title":"PLoS One"},{"issue":"16","key":"1183_CR68","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1038\/emboj.2011.225","volume":"30","author":"I Gonzalez-Suarez","year":"2011","unstructured":"I. Gonzalez-Suarez, A.B. Redwood, D.A. Grotsky, M.A. Neumann, E.H. Cheng, C.L. Stewart, A. Dusso, S. Gonzalo, A new pathway that regulates 53BP1 stability implicates cathepsin L and vitamin D in DNA repair. Embo j. 30(16), 3383\u20133396 (2011)","journal-title":"Embo j."},{"key":"1183_CR69","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2021.04.019","volume":"169","author":"R Jia","year":"2021","unstructured":"R. Jia, F. Yang, P. Yan, L. Ma, L. Yang, L. Li, Paricalcitol inhibits oxidative stress-induced cell senescence of the bile duct epithelium dependent on modulating Sirt1 pathway in cholestatic mice. Free Radic Biol. Med. 169, 158\u2013168 (2021)","journal-title":"Free Radic Biol. Med."},{"issue":"4","key":"1183_CR70","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/hep.30887","volume":"71","author":"Y Zhou","year":"2020","unstructured":"Y. Zhou, B. Dong, K.H. Kim, S. Choi, Z. Sun, N. Wu, Y. Wu, J. Scott, D.D. Moore, Vitamin D receptor activation in liver macrophages protects against hepatic endoplasmic reticulum stress in mice. Hepatology. 71(4), 1453\u20131466 (2020)","journal-title":"Hepatology"},{"issue":"1","key":"1183_CR71","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/path.5750","volume":"255","author":"J Xie","year":"2021","unstructured":"J. Xie, Y. Fan, R. Jia, F. Yang, L. Ma, L. Li, Yes-associated protein regulates the hepatoprotective effect of vitamin D receptor activation through promoting adaptive bile duct remodeling in cholestatic mice. J. Pathol. 255(1), 95\u2013106 (2021)","journal-title":"J. Pathol."},{"issue":"4","key":"1183_CR72","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.jcmgh.2022.10.011","volume":"15","author":"Z Zheng","year":"2023","unstructured":"Z. Zheng, J. Xie, L. Ma, Z. Hao, W. Zhang, L. Li, Vitamin D receptor activation targets ROS-mediated crosstalk between autophagy and apoptosis in hepatocytes in cholestasic mice. Cell. Mol. Gastroenterol. Hepatol. 15(4), 887\u2013901 (2023)","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"3","key":"1183_CR73","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ajpath.2023.11.016","volume":"194","author":"T Wen","year":"2024","unstructured":"T. Wen, J. Xie, L. Ma, Z. Hao, W. Zhang, T. Wu, L. Li, Vitamin D Receptor Activation Reduces Hepatic Inflammation via Enhancing Macrophage Autophagy in Cholestatic Mice. Am. J. Pathol. 194(3), 369\u2013383 (2024)","journal-title":"Am. J. Pathol."},{"issue":"12","key":"1183_CR74","doi-asserted-by":"publisher","first-page":"6287","DOI":"10.4049\/jimmunol.164.12.6287","volume":"164","author":"E Junn","year":"2000","unstructured":"E. Junn, S.H. Han, J.Y. Im, Y. Yang, E.W. Cho, H.D. Um, D.K. Kim, K.W. Lee, P.L. Han, S.G. Rhee, Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J. Immunol. 164(12), 6287\u20136295 (2000)","journal-title":"J. Immunol."},{"issue":"7","key":"1183_CR75","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s12276-023-01019-8","volume":"55","author":"E-H Choi","year":"2023","unstructured":"E.-H. Choi, S.-J. Park, TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target. Exp. Mol. Med. 55(7), 1348\u20131356 (2023)","journal-title":"Exp. Mol. Med."},{"issue":"24","key":"1183_CR76","doi-asserted-by":"publisher","first-page":"9357","DOI":"10.3390\/ijms21249357","volume":"21","author":"H Tsubaki","year":"2020","unstructured":"H. Tsubaki, I. Tooyama, D.G. Walker, Thioredoxin-interacting protein (TXNIP) with focus on brain and neurodegenerative diseases. Int. J. Mol. Sci. 21(24), 9357 (2020)","journal-title":"Int. J. Mol. Sci."},{"key":"1183_CR77","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fimmu.2013.00514","volume":"4","author":"E Yoshihara","year":"2014","unstructured":"E. Yoshihara, S. Masaki, Y. Matsuo, Z. Chen, H. Tian, J. Yodoi, Thioredoxin\/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases. Front. Immunol. 4, 514 (2014)","journal-title":"Front. Immunol."},{"issue":"1","key":"1183_CR78","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"J. Zheng, S. Wang, L. Xia, Z. Sun, K.M. Chan, R. Bernards, W. Qin, J. Chen, Q. Xia, H. Jin, Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal. Transduct. Target. therapy. 10(1), 35 (2025)","journal-title":"Signal. Transduct. Target. therapy"},{"issue":"13","key":"1183_CR79","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/hepr.12302","volume":"44","author":"JP Hamilton","year":"2014","unstructured":"J.P. Hamilton, J.J. Potter, L. Koganti, S.J. Meltzer, E. Mezey, Effects of vitamin D3 stimulation of thioredoxin-interacting protein in hepatocellular carcinoma. Hepatol. Res. 44(13), 1357\u20131366 (2014)","journal-title":"Hepatol. Res."},{"issue":"1","key":"1183_CR80","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1038\/s41467-025-59724-z","volume":"16","author":"EB Baek","year":"2025","unstructured":"E.B. Baek, H.S. Eun, J.-Y. Song, E.-J. Hong, S.-H. Park, P. Kumbukgahadeniya, S.-M. Park, S.-H. Kim, S.O. Kim, H.N. Kim, Vitamin D supplementation ameliorates ductular reaction, liver inflammation and fibrosis in mice by upregulating TXNIP in ductular cells. Nat. Commun. 16(1), 4420 (2025)","journal-title":"Nat. Commun."},{"issue":"3","key":"1183_CR81","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3390\/ijms24032652","volume":"24","author":"L-Y Tian","year":"2023","unstructured":"L.-Y. Tian, D.J. Smit, M. J\u00fccker, The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism. Int. J. Mol. Sci. 24(3), 2652 (2023)","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"1183_CR82","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1535-6108(03)00248-4","volume":"4","author":"J Luo","year":"2003","unstructured":"J. Luo, B.D. Manning, L.C. Cantley, Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer cell. 4(4), 257\u2013262 (2003)","journal-title":"Cancer cell."},{"issue":"1","key":"1183_CR83","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"N. Koundouros, G. Poulogiannis, Reprogramming of fatty acid metabolism in cancer. Br. J. Cancer. 122(1), 4\u201322 (2020)","journal-title":"Br. J. Cancer"},{"issue":"3","key":"1183_CR84","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3892\/or.2017.5848","volume":"38","author":"J Huang","year":"2017","unstructured":"J. Huang, G. Yang, Y. Huang, S. Zhang, Inhibitory effects of 1, 25 (OH) 2D3 on the proliferation of hepatocellular carcinoma cells through the downregulation of HDAC2. Oncol. Rep. 38(3), 1845\u20131850 (2017)","journal-title":"Oncol. Rep."},{"issue":"2","key":"1183_CR85","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1600-079X.2010.00824.x","volume":"50","author":"S Proietti","year":"2011","unstructured":"S. Proietti, A. Cucina, F. D\u2019Anselmi, S. Dinicola, A. Pasqualato, E. Lisi, M. Bizzarri, Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGF\u03b2\u20101\u2010dependent growth inhibition of breast cancer cells. J. Pineal Res. 50(2), 150\u2013158 (2011)","journal-title":"J. Pineal Res."},{"issue":"11","key":"1183_CR86","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.3390\/cells9112440","volume":"9","author":"I-M Gkotinakou","year":"2020","unstructured":"I.-M. Gkotinakou, E. Kechagia, K. Pazaitou-Panayiotou, I. Mylonis, P. Liakos, A. Tsakalof, Calcitriol suppresses HIF-1 and HIF-2 transcriptional activity by reducing HIF-1\/2\u03b1 protein levels via a VDR-independent mechanism. Cells. 9(11), 2440 (2020)","journal-title":"Cells"},{"issue":"1","key":"1183_CR87","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00018-024-05537-0","volume":"82","author":"Y Shi","year":"2025","unstructured":"Y. Shi, D.M. Gilkes, HIF-1 and HIF-2 in cancer: Structure, regulation, and therapeutic prospects. Cell. Mol. Life Sci. 82(1), 44 (2025)","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"1183_CR88","doi-asserted-by":"publisher","first-page":"418","DOI":"10.18632\/oncotarget.23063","volume":"9","author":"D-P Chen","year":"2017","unstructured":"D.-P. Chen, Y.-P. Ma, L. Zhuo, Z. Zhang, G.-M. Zou, Y. Yang, H.-M. Gao, W.-G. Li, 1, 25-Dihydroxyvitamin D3 inhibits the proliferation of rat mesangial cells induced by high glucose via DDIT4. Oncotarget. 9(1), 418 (2017)","journal-title":"Oncotarget"},{"issue":"10","key":"1183_CR89","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1073\/pnas.0907705107","volume":"107","author":"P Horak","year":"2010","unstructured":"P. Horak, A.R. Crawford, D.D. Vadysirisack, Z.M. Nash, M.P. DeYoung, D. Sgroi, L.W. Ellisen, Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc. Natl. Acad. Sci. U S A 107(10), 4675\u20134680 (2010)","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"12","key":"1183_CR90","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.3390\/biomedicines11123280","volume":"11","author":"N Li","year":"2023","unstructured":"N. Li, X. Li, Y. Ding, X. Liu, K. Diggle, T. Kisseleva, D.A. Brenner, SREBP regulation of lipid metabolism in liver disease, and therapeutic strategies. Biomedicines. 11(12), 3280 (2023)","journal-title":"Biomedicines"},{"issue":"1","key":"1183_CR91","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s41467-020-14811-1","volume":"11","author":"A Loregger","year":"2020","unstructured":"A. Loregger, M. Raaben, J. Nieuwenhuis, J.M. Tan, L.T. Jae, van den L.G. Hengel, S. Hendrix, van den M. Berg, S. Scheij, J.-Y. Song, Haploid genetic screens identify SPRING\/C12ORF49 as a determinant of SREBP signaling and cholesterol metabolism. Nat. Commun. 11(1), 1128 (2020)","journal-title":"Nat. Commun."},{"issue":"2","key":"1183_CR92","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10555-023-10156-5","volume":"43","author":"F Su","year":"2024","unstructured":"F. Su, A. Koeberle, Regulation and targeting of SREBP-1 in hepatocellular carcinoma. Cancer Metastasis Rev. 43(2), 673\u2013708 (2024)","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"1183_CR93","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41698-024-00545-6","volume":"8","author":"Y Wang","year":"2024","unstructured":"Y. Wang, Z. Zhao, T. Guo, T. Wu, M. Zhang, D. Luo, K. Dou, Y. Yang, C. Jin, B. Zhang, SOCS5-RBMX stimulates SREBP1-mediated lipogenesis to promote metastasis in steatotic HCC with HBV-related cirrhosis. NPJ Precision Oncol. 8(1), 58 (2024)","journal-title":"NPJ Precision Oncol."},{"issue":"50","key":"1183_CR94","doi-asserted-by":"publisher","first-page":"52772","DOI":"10.1074\/jbc.M410302200","volume":"279","author":"CM Adams","year":"2004","unstructured":"C.M. Adams, J. Reitz, De J.K. Brabander, J.D. Feramisco, L. Li, M.S. Brown, J.L. Goldstein, Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J. Biol. Chem. 279(50), 52772\u201352780 (2004)","journal-title":"J. Biol. Chem."},{"issue":"2","key":"1183_CR95","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chembiol.2016.12.017","volume":"24","author":"L Asano","year":"2017","unstructured":"L. Asano, M. Watanabe, Y. Ryoden, K. Usuda, T. Yamaguchi, B. Khambu, M. Takashima, S.-. Sato, J. Sakai, K. Nagasawa, Vitamin D metabolite, 25-hydroxyvitamin D, regulates lipid metabolism by inducing degradation of SREBP\/SCAP. Cell. Chem. biology. 24(2), 207\u2013217 (2017)","journal-title":"Cell. Chem. biology"},{"issue":"3","key":"1183_CR96","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0092-8674(00)81362-8","volume":"87","author":"X Hua","year":"1996","unstructured":"X. Hua, A. Nohturfft, J.L. Goldstein, M.S. Brown, Sterol resistance in CHO cells traced to point mutation in SREBP cleavage\u2013activating protein. Cell. 87(3), 415\u2013426 (1996)","journal-title":"Cell"},{"key":"1183_CR97","doi-asserted-by":"crossref","unstructured":"D. Reda, G.E. Elshopakey, T.A. Albukhari, S.J. Almehmadi, B. Refaat, E.F. Risha, H.A. Mahgoub, M.E. El-Boshy, F.M. Abdelhamid, Vitamin D3 alleviates nonalcoholic fatty liver disease in rats by inhibiting hepatic oxidative stress and inflammation via the SREBP-1-c\/ PPAR\u03b1-NF-\u03baB\/IR-S2 signaling pathway. Front. Pharmacol. 14, (2023)","DOI":"10.3389\/fphar.2023.1164512"},{"issue":"1","key":"1183_CR98","doi-asserted-by":"publisher","first-page":"436","DOI":"10.7150\/thno.90322","volume":"14","author":"LN Qin","year":"2024","unstructured":"L.N. Qin, H. Zhang, Q.Q. Li, T. Wu, S.B. Cheng, K.W. Wang, Y. Shi, H.R. Ren, X.W. Xing, C. Yang et al., Vitamin D binding protein (VDBP) hijacks twist1 to inhibit vasculogenic mimicry in hepatocellular carcinoma. Theranostics. 14(1), 436\u2013450 (2024)","journal-title":"Theranostics"},{"issue":"4","key":"1183_CR99","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.7150\/ijbs.89568","volume":"20","author":"X Xin","year":"2024","unstructured":"X. Xin, X. Cheng, F. Zeng, Q. Xu, L. Hou, The role of TGF-\u03b2\/SMAD signaling in hepatocellular carcinoma: from mechanism to therapy and prognosis. Int. J. Biol. Sci. 20(4), 1436 (2024)","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"1183_CR100","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.7150\/ijbs.89568","volume":"20","author":"X Xin","year":"2024","unstructured":"X. Xin, X. Cheng, F. Zeng, Q. Xu, L. Hou, The Role of TGF-\u03b2\/SMAD Signaling in Hepatocellular Carcinoma: from Mechanism to Therapy and Prognosis. Int. J. Biol. Sci. 20(4), 1436\u20131451 (2024)","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"1183_CR101","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1097-2765(02)00585-3","volume":"10","author":"GJ Inman","year":"2002","unstructured":"G.J. Inman, F.J. Nicol\u00e1s, C.S. Hill, Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-\u03b2 receptor activity. Mol. Cell. 10(2), 283\u2013294 (2002)","journal-title":"Mol. Cell"},{"issue":"5","key":"1183_CR102","doi-asserted-by":"publisher","first-page":"e0156090","DOI":"10.1371\/journal.pone.0156090","volume":"11","author":"L Niu","year":"2016","unstructured":"L. Niu, X. Cui, Y. Qi, D. Xie, Q. Wu, X. Chen, J. Ge, Z. Liu, Involvement of TGF-\u03b21\/Smad3 signaling in carbon tetrachloride-induced acute liver injury in mice. PLoS One. 11(5), e0156090 (2016)","journal-title":"PLoS One"},{"key":"1183_CR103","doi-asserted-by":"publisher","first-page":"109355","DOI":"10.1016\/j.cbi.2020.109355","volume":"334","author":"W Lu","year":"2021","unstructured":"W. Lu, X. Li, N. Liu, Y. Zhang, Y. Li, Y. Pan, J. Yang, Z. Liu, J. Kong, Vitamin D alleviates liver fibrosis by inhibiting histidine-rich calcium binding protein (HRC). Chemico-Biol. Interact. 334, 109355 (2021)","journal-title":"Chemico-Biol. Interact."},{"issue":"3","key":"1183_CR104","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.3892\/etm.2017.4836","volume":"14","author":"SP Wu","year":"2017","unstructured":"S.P. Wu, Z. Yang, F.R. Li, X.D. Liu, H.T. Chen, D.N. Su, Smad7-overexpressing rat BMSCs inhibit the fibrosis of hepatic stellate cells by regulating the TGF-\u03b21\/Smad signaling pathway. Exp. Ther. Med. 14(3), 2568\u20132576 (2017)","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"1183_CR105","doi-asserted-by":"publisher","first-page":"30217","DOI":"10.1038\/srep30217","volume":"6","author":"J Chen","year":"2016","unstructured":"J. Chen, L.H. Katz, N.M. Mu\u00f1oz, S. Gu, J.-. Shin, W.S. Jogunoori, M.-H. Lee, M.D. Belkin, S.-B. Kim, J.C. White, Vitamin D deficiency promotes liver tumor growth in transforming growth factor-\u03b2\/Smad3-deficient mice through Wnt and toll-like receptor 7 pathway modulation. Sci. Rep. 6(1), 30217 (2016)","journal-title":"Sci. Rep."},{"key":"1183_CR106","doi-asserted-by":"publisher","first-page":"135480","DOI":"10.1016\/j.jhazmat.2024.135480","volume":"478","author":"P Wang","year":"2024","unstructured":"P. Wang, J. Li, M. Ji, J. Pan, Y. Cao, Y. Kong, L. Zhu, J. Li, B. Li, L. Chang et al., Vitamin D receptor attenuates carbon tetrachloride-induced liver fibrosis via downregulation of YAP. J. Hazard. Mater. 478, 135480 (2024)","journal-title":"J. Hazard. Mater."},{"key":"1183_CR107","doi-asserted-by":"publisher","first-page":"117059","DOI":"10.1016\/j.bcp.2025.117059","volume":"240","author":"X Liu","year":"2025","unstructured":"X. Liu, Y. Wu, C. Guan, N. Cheng, X. Wang, Y. Liu, J. Chen, C. Wang, Vitamin D receptor agonists inhibit liver fibrosis by disrupting the interaction between hepatic stellate cells and neutrophil extracellular traps. Biochem. Pharmacol. 240, 117059 (2025)","journal-title":"Biochem. Pharmacol."},{"key":"1183_CR108","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsbmb.2015.06.008","volume":"154","author":"KC Chiang","year":"2015","unstructured":"K.C. Chiang, C.L. Yen, C.N. Yeh, J.T. Hsu, L.W. Chen, S.F. Kuo, S.Y. Wang, C.C. Sun, A. Kittaka, T.C. Chen et al., Hepatocellular carcinoma cells express 25(OH)D-1\u03b1-hydroxylase and are able to convert 25(OH)D to 1\u03b1,25(OH)\u2082D, leading to the 25(OH)D-induced growth inhibition. J. Steroid Biochem. Mol. Biol. 154, 47\u201352 (2015)","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"05","key":"1183_CR109","doi-asserted-by":"publisher","first-page":"A31","DOI":"10.1055\/s-0032-1312385","volume":"50","author":"E Horvath","year":"2012","unstructured":"E. Horvath, P. Lakatos, B. Balla, J. K\u00f3sa, B. T\u00f3bi\u00e1s, \u00c1. Somor\u00e1cz, H. Jozilan, L. Hars\u00e1nyi, P. Kupcsulik, Z. Schaff, CYP24A1 and CYP27B1 MRNA expression in human hepatocellular carcinoma. Z. Gastroenterol. 50(05), A31 (2012)","journal-title":"Z. Gastroenterol."},{"key":"1183_CR110","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.biopha.2018.08.153","volume":"107","author":"J Xu","year":"2018","unstructured":"J. Xu, Y. Wang, Y. Zhang, S. Dang, S. He, Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC. Biomed. Pharmacother. 107, 1682\u20131691 (2018)","journal-title":"Biomed. Pharmacother."},{"key":"1183_CR111","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jsbmb.2004.03.084","volume":"89","author":"PL Shaffer","year":"2004","unstructured":"P.L. Shaffer, D.T. Gewirth, Structural analysis of RXR\u2013VDR interactions on DR3 DNA. J. Steroid Biochem. Mol. Biol. 89, 215\u2013219 (2004)","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"20","key":"1183_CR112","first-page":"7675","volume":"61","author":"R Matsushima-Nishiwaki","year":"2001","unstructured":"R. Matsushima-Nishiwaki, M. Okuno, S. Adachi, T. Sano, K. Akita, H. Moriwaki, S.L. Friedman, S. Kojima, Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma. Cancer Res. 61(20), 7675\u20137682 (2001)","journal-title":"Cancer Res."},{"issue":"8","key":"1183_CR113","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1074\/jbc.M707517200","volume":"283","author":"M Macoritto","year":"2008","unstructured":"M. Macoritto, L. Nguyen-Yamamoto, D.C. Huang, S. Samuel, X.F. Yang, T.T. Wang, J.H. White, R. Kremer, Phosphorylation of the human retinoid X receptor alpha at serine 260 impairs coactivator(s) recruitment and induces hormone resistance to multiple ligands. J. Biol. Chem. 283(8), 4943\u20134956 (2008)","journal-title":"J. Biol. Chem."},{"issue":"4","key":"1183_CR114","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1074\/jbc.M116.758185","volume":"292","author":"S Jusu","year":"2017","unstructured":"S. Jusu, J.F. Presley, R. Kremer, Phosphorylation of Human Retinoid X Receptor \u03b1 at Serine 260 Impairs Its Subcellular Localization, Receptor Interaction, Nuclear Mobility, and 1\u03b1,25-Dihydroxyvitamin D3-dependent DNA Binding in Ras-transformed Keratinocytes. J. Biol. Chem. 292(4), 1490\u20131509 (2017)","journal-title":"J. Biol. Chem."},{"issue":"3","key":"1183_CR115","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/carcin\/bgab099","volume":"43","author":"H Sakai","year":"2022","unstructured":"H. Sakai, Y. Yamada, M. Kubota, K. Imai, Y. Shirakami, H. Tomita, A. Hara, M. Shimizu, The phosphorylated retinoid X receptor-\u03b1 promotes diethylnitrosamine-induced hepatocarcinogenesis in mice through the activation of \u03b2-catenin signaling pathway. Carcinogenesis. 43(3), 254\u2013263 (2022)","journal-title":"Carcinogenesis"},{"issue":"1","key":"1183_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17998\/jlc.21.1.1","volume":"21","author":"H Moon","year":"2021","unstructured":"H. Moon, S.W. Ro, Ras mitogen-activated protein kinase signaling and kinase suppressor of ras as therapeutic targets for hepatocellular carcinoma. J. liver cancer. 21(1), 1\u201311 (2021)","journal-title":"J. liver cancer"},{"issue":"3","key":"1183_CR117","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000348441","volume":"87","author":"CD Fingas","year":"2013","unstructured":"C.D. Fingas, A. Altinbas, M. Schlattjan, A. Beilfuss, J.P. Sowa, S. Sydor, L.P. Bechmann, J. Ertle, H. Akkiz, K. Herzer et al., Expression of apoptosis- and vitamin D pathway-related genes in hepatocellular carcinoma. Digestion. 87(3), 176\u2013181 (2013)","journal-title":"Digestion"},{"issue":"3","key":"1183_CR118","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1053\/j.gastro.2012.05.043","volume":"143","author":"Q Li","year":"2012","unstructured":"Q. Li, Y. Gao, Z. Jia, L. Mishra, K. Guo, Z. Li, X. Le, D. Wei, S. Huang, K. Xie, Dysregulated Kr\u00fcppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma. Gastroenterology. 143(3), 799\u2013810e792 (2012)","journal-title":"Gastroenterology"},{"issue":"1","key":"1183_CR119","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s10020-018-0055-0","volume":"24","author":"N Gotlieb","year":"2018","unstructured":"N. Gotlieb, I. Tachlytski, Y. Lapidot, M. Sultan, M. Safran, Z. Ben-Ari, Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production. Mol. Med. 24(1), 53 (2018)","journal-title":"Mol. Med."},{"key":"1183_CR120","doi-asserted-by":"crossref","unstructured":"S. Ahluwalia, D. Choudhary, P. Tyagi, V. Kumar, P. Vivekanandan, Vitamin D signaling inhibits HBV activity by directly targeting the HBV core promoter. J. Biol. Chem. 297(4), (2021)","DOI":"10.1016\/j.jbc.2021.101233"},{"key":"1183_CR121","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.gene.2018.02.024","volume":"653","author":"M Abdalla","year":"2018","unstructured":"M. Abdalla, E. Khairy, M.L. Louka, R. Ali-Labib, E.A. Ibrahim, Vitamin D receptor gene methylation in hepatocellular carcinoma. Gene. 653, 65\u201371 (2018)","journal-title":"Gene"},{"key":"1183_CR122","doi-asserted-by":"publisher","first-page":"151547","DOI":"10.1016\/j.bbrc.2025.151547","volume":"755","author":"S Kimura","year":"2025","unstructured":"S. Kimura, S. Tagami, H. Mano, A. Kittaka, Y. Ida, Y. Takagi, K. Nakagawa, T. Arai, S. Yokota, N. Tsugawa, Divergent roles of 25-hydroxyvitamin D3 and 1\u03b1, 25-dihydroxyvitamin D3 in neural fate determination: A CYP27B1-dependent neuron formation and VDR-dependent astrocyte development. Biochem. Biophys. Res. Commun. 755, 151547 (2025)","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1183_CR123","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsbmb.2015.06.008","volume":"154","author":"K-C Chiang","year":"2015","unstructured":"K.-C. Chiang, C.-L. Yen, C.-N. Yeh, J.-T. Hsu, L.-W. Chen, S.-F. Kuo, S.-Y. Wang, C.-C. Sun, A. Kittaka, T.C. Chen, Hepatocellular carcinoma cells express 25 (OH) D-1\u03b1-hydroxylase and are able to convert 25 (OH) D to 1\u03b1, 25 (OH) 2D, leading to the 25 (OH) D-induced growth inhibition. J. Steroid Biochem. Mol. Biol. 154, 47\u201352 (2015)","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"Pt","key":"1183_CR124","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jsbmb.2013.09.017","volume":"144","author":"DM Hummel","year":"2014","unstructured":"D.M. Hummel, I.S. Fetahu, C. Gr\u00f6schel, T. Manhardt, E. K\u00e1llay, Role of proinflammatory cytokines on expression of vitamin D metabolism and target genes in colon cancer cells. J. Steroid Biochem. Mol. Biol. 144(Pt), 91\u201395 (2014)","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"Pt","key":"1183_CR125","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jsbmb.2013.12.007","volume":"144","author":"N Noyola-Mart\u00ednez","year":"2014","unstructured":"N. Noyola-Mart\u00ednez, L. D\u00edaz, V. Zaga-Clavellina, E. Avila, A. Halhali, F. Larrea, D. Barrera, Regulation of CYP27B1 and CYP24A1 gene expression by recombinant pro-inflammatory cytokines in cultured human trophoblasts. J. Steroid Biochem. Mol. Biol. 144(Pt), 106\u2013109 (2014)","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"1183_CR126","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.4049\/jimmunol.0803345","volume":"182","author":"L Sz\u00e9les","year":"2009","unstructured":"L. Sz\u00e9les, G. Keresztes, Z. T\u00f6r\u00f6csik Dn, Balajthy, L. Kren\u00e1cs, S. P\u00f3liska, A. Steinmeyer, U. Zuegel, M. Pruenster, A. Rot, 1, 25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J. Immunol. 182(4), 2074\u20132083 (2009)","journal-title":"J. Immunol."},{"issue":"20","key":"1183_CR127","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1073\/pnas.0402490101","volume":"101","author":"JB Cheng","year":"2004","unstructured":"J.B. Cheng, M.A. Levine, N.H. Bell, D.J. Mangelsdorf, D.W. Russell, Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. U S A 101(20), 7711\u20137715 (2004)","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"7","key":"1183_CR128","doi-asserted-by":"publisher","first-page":"bqac060","DOI":"10.1210\/endocr\/bqac060","volume":"163","author":"M-S Elkhwanky","year":"2022","unstructured":"M.-S. Elkhwanky, O. Kummu, J. Hakkola, Streptozotocin-induced diabetes represses hepatic CYP2R1 expression but induces vitamin D 25-hydroxylation in male mice. Endocrinology. 163(7), bqac060 (2022)","journal-title":"Endocrinology"},{"issue":"4","key":"1183_CR129","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/hep.27079","volume":"60","author":"V Fedirko","year":"2014","unstructured":"V. Fedirko, T. Duarte-Salles, C. Bamia, A. Trichopoulou, K. Aleksandrova, D. Trichopoulos, E. Trepo, A. Tj\u00f8nneland, A. Olsen, K. Overvad et al., Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study. Hepatology. 60(4), 1222\u20131230 (2014)","journal-title":"Hepatology"},{"issue":"5","key":"1183_CR130","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1089\/gtmb.2018.0170","volume":"23","author":"P Barooah","year":"2019","unstructured":"P. Barooah, S. Saikia, R. Bharadwaj, P. Sarmah, M. Bhattacharyya, B. Goswami, S. Medhi, Role of VDR, GC, and CYP2R1 Polymorphisms in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients. Genet. Test. Mol. Biomarkers. 23(5), 325\u2013331 (2019)","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"1183_CR131","doi-asserted-by":"publisher","first-page":"108889","DOI":"10.1016\/j.abb.2021.108889","volume":"704","author":"AE Angeli-Terzidou","year":"2021","unstructured":"A.E. Angeli-Terzidou, I.M. Gkotinakou, K. Pazaitou-Panayiotou, A. Tsakalof, Inhibition of calcitriol inactivating enzyme CYP24A1 gene expression by flavonoids in hepatocellular carcinoma cells under normoxia and hypoxia. Arch. Biochem. Biophys. 704, 108889 (2021)","journal-title":"Arch. Biochem. Biophys."},{"issue":"19","key":"1183_CR132","doi-asserted-by":"publisher","first-page":"e37998","DOI":"10.1097\/MD.0000000000037998","volume":"103","author":"T Wang","year":"2024","unstructured":"T. Wang, L. Han, J. Xu, B. Guo, Identification of vitamin D-related signature for predicting the clinical outcome and immunotherapy response in hepatocellular carcinoma. Medicine. 103(19), e37998 (2024)","journal-title":"Medicine"},{"key":"1183_CR133","doi-asserted-by":"crossref","unstructured":"de B. Jesus Brait, da S.P. Silva Lima, F.L. Aguiar, R. Fernandes-Ferreira, C.I.F. Oliveira-Brancati, J.A.M.L. Ferraz, G.D. Tenani, de M.A. Souza Pinhel, L.C.P. Assoni, A.H. Nakahara, Genetic polymorphisms related to the vitamin D pathway in patients with cirrhosis with or without hepatocellular carcinoma (HCC). ecancermedicalscience 16, 1383 (2022)","DOI":"10.3332\/ecancer.2022.1383"},{"issue":"9","key":"1183_CR134","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1210\/en.2009-1156","volume":"151","author":"JR Muindi","year":"2010","unstructured":"J.R. Muindi, W.-D. Yu, Y. Ma, K.L. Engler, R.-X. Kong, D.L. Trump, C.S. Johnson, CYP24A1 inhibition enhances the antitumor activity of calcitriol. Endocrinology. 151(9), 4301\u20134312 (2010)","journal-title":"Endocrinology"},{"key":"1183_CR135","doi-asserted-by":"publisher","first-page":"106022","DOI":"10.1016\/j.jsbmb.2021.106022","volume":"215","author":"RL Goto","year":"2022","unstructured":"R.L. Goto, M.B. Tablas, G.B. Prata, S.G.E. Santo, A.A.H. Fernandes, B. Cogliati, L.F. Barbisan, G.R. Romualdo, Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis. J. Steroid Biochem. Mol. Biol. 215, 106022 (2022)","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"1183_CR136","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/sj.bjc.6601104","volume":"89","author":"K Dalhoff","year":"2003","unstructured":"K. Dalhoff, J. Dancey, L. Astrup, T. Skovsgaard, K. Hamberg, F. Lofts, O. Rosmorduc, S. Erlinger, J. Bach Hansen, W. Steward, A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma. Br. J. Cancer. 89(2), 252\u2013257 (2003)","journal-title":"Br. J. Cancer"},{"key":"1183_CR137","doi-asserted-by":"publisher","first-page":"e10709","DOI":"10.7717\/peerj.10709","volume":"9","author":"S Sriphoosanaphan","year":"2021","unstructured":"S. Sriphoosanaphan, K. Thanapirom, S.J. Kerr, S. Suksawatamnuay, P. Thaimai, S. Sittisomwong, K. Sonsiri, N. Srisoonthorn, N. Teeratorn, N. Tanpowpong, Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: A randomized, double-blind, placebo-controlled trial. PeerJ. 9, e10709 (2021)","journal-title":"PeerJ"},{"issue":"1","key":"1183_CR138","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12937-024-00911-x","volume":"23","author":"S Ebrahimpour-Koujan","year":"2024","unstructured":"S. Ebrahimpour-Koujan, A.A. Sohrabpour, E. Giovannucci, A. Vatannejad, A. Esmaillzadeh, Effects of vitamin D supplementation on liver fibrogenic factors, vitamin D receptor and liver fibrogenic microRNAs in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: an exploratory randomized clinical trial. Nutr. J. 23(1), 24 (2024)","journal-title":"Nutr. J."},{"issue":"2","key":"1183_CR139","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/17461391.2019.1635649","volume":"20","author":"D Pastuszak-Lewandoska","year":"2020","unstructured":"D. Pastuszak-Lewandoska, D. Doma\u0144ska-Senderowska, J. Kisza\u0142kiewicz, P. Szmigielska, A. Snochowska, W. Ratkowski, M. Spieszny, T. Klocek, P. Godlewski, P. Ci\u0119szczyk, Expression levels of selected cytokines and microRNAs in response to vitamin D supplementation in ultra-marathon runners. Eur. J. Sport Sci. 20(2), 219\u2013228 (2020)","journal-title":"Eur. J. Sport Sci."},{"key":"1183_CR140","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jsbmb.2016.09.024","volume":"173","author":"AT Slominski","year":"2017","unstructured":"A.T. Slominski, T.-K. Kim, J.V. Hobrath, A.S. Oak, E.K. Tang, E.W. Tieu, W. Li, R.C. Tuckey, A.M. Jetten, Endogenously produced nonclassical vitamin D hydroxy-metabolites act as biased agonists on VDR and inverse agonists on ROR\u03b1 and ROR\u03b3. J. Steroid Biochem. Mol. Biol. 173, 42\u201356 (2017)","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"1183_CR141","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3892\/ijo.2022.5386","volume":"61","author":"AT Slominski","year":"2022","unstructured":"A.T. Slominski, A.A. Bro\u017cyna, T.-K. Kim, M.M. Elsayed, Z. Janjetovic, S. Qayyum, R.M. Slominski, A.S. Oak, C. Li, E. Podgorska, CYP11A1-derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas. Int. J. Oncol. 61(2), 96 (2022)","journal-title":"Int. J. Oncol."},{"issue":"1","key":"1183_CR142","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/s41598-018-19183-7","volume":"8","author":"Z Lin","year":"2018","unstructured":"Z. Lin, S.R. Marepally, E.S. Goh, C.Y. Cheng, Z. Janjetovic, T.-K. Kim, D.D. Miller, A.E. Postlethwaite, A.T. Slominski, R.C. Tuckey, Investigation of 20 S-hydroxyvitamin D3 analogs and their 1\u03b1-OH derivatives as potent vitamin D receptor agonists with anti-inflammatory activities. Sci. Rep. 8(1), 1478 (2018)","journal-title":"Sci. Rep."},{"issue":"1","key":"1183_CR143","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.31013","volume":"72","author":"AP Fang","year":"2020","unstructured":"A.P. Fang, J.A. Long, Y.J. Zhang, Z.Y. Liu, Q.J. Li, D.M. Zhang, Y. Luo, R.H. Zhong, Z.G. Zhou, Y.J. Xu et al., Serum Bioavailable, Rather Than Total, 25-hydroxyvitamin D Levels Are Associated With Hepatocellular Carcinoma Survival. Hepatology. 72(1), 169\u2013182 (2020)","journal-title":"Hepatology"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01183-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01183-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01183-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:02:51Z","timestamp":1773244971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01183-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":143,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1183"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01183-9","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}